First human test of new heart health drug combo
NCT ID NCT06889012
Summary
This early-stage study tested how the body absorbs and processes a new combination drug called BR1018, intended for high blood pressure and high cholesterol. Researchers gave single doses to 60 healthy volunteers to measure drug levels in the blood and check for safety. The goal was to understand how the drug behaves in people before testing it in patients with the actual conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Center, H PLUS Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.